About Immunostics
Immunostics is a company based in Ocean Township (United States) founded in 1983 was acquired by Boditech Med in March 2016. Immunostics has raised $3.7 million across 2 funding rounds from investors including Boditech Med. The company has 15 employees as of December 31, 2022. Immunostics offers products and services including hemochroma PLUS, hema-screen SPECIFIC GOLD, and Swab-N-Go Home Test COVID-19 Ag.
- Headquarter Ocean Township, United States
- Employees 15 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Immunostics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.7 M (USD)
in 2 rounds
-
Latest Funding Round
$3 M (USD), Series A
Dec 12, 2016
- Investors
-
Employee Count
15
as on Dec 31, 2022
-
Acquired by
Boditech Med
(Mar 02, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Immunostics
Immunostics offers a comprehensive portfolio of products and services, including hemochroma PLUS, hema-screen SPECIFIC GOLD, and Swab-N-Go Home Test COVID-19 Ag.
Device for testing heart disease and hormonal disorders.
Test for detecting blood in stool related to cancer.
Rapid antigen test for COVID-19 detection at home.
Funding Insights of Immunostics
Immunostics has successfully raised a total of $3.7M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Immunostics
Immunostics has secured backing from 1 investor. Prominent investors backing the company include Boditech Med.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developing in vitro diagnostics analyzer instruments and reagents
|
Locked | Locked | Locked |
Investor details for Immunostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Immunostics
Investment portfolio details for Immunostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Immunostics
Detailed financials for Immunostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immunostics Comparisons
Peer comparison for Immunostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Immunostics
Detailed competitors of Immunostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immunostics
Complete news archive for Immunostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immunostics
Immunostics was founded in 1983 and raised its 1st funding round 33 years after it was founded.
Immunostics is headquartered in Ocean Township, United States. It is registered at Ocean Township, New Jersey, United States.
Immunostics is a funded company, having raised a total of $3.7M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Immunostics is 15.
Immunostics develops microbiological, serological and immunological diagnostic kits and reagents. The company offers products covering a wide range of disease areas such as oncology, womens health, infectious disease, respiratory and toxicology. It also develops and market a wide range of lateral flow tests including Fecal Occult Blood, Strep, Pregnancy, Mono, H. Pylori,etc. The company was sold in March 2016 and operates as a subsidiary of Boditech Med.
Immunostics offers hemochroma PLUS, hema-screen SPECIFIC GOLD, and Swab-N-Go Home Test COVID-19 Ag.
Immunostics has 1 investor. Key investors include Boditech Med.